{"metadata": {"organization_names": ["myriad phase v"], "person_names_verified": ["adrian n. hobden", "peter d. meldrum"], "organization_names_verified": ["the boyer company l.c.", "the boyer company", "boyer research park associates ix", "{myriad genetics inc", "myriad pharmaceuticals inc", "myriad genetics inc", "myriad genetics", "myriad pharmaceuticals", "myriad genetics, inc.", "myriad pharmaceuticals, inc.", "research park building - phase v"], "topics": [], "entities_rejected": [], "person_names": [], "agreement_id": "c5d8f26d4fb10151196880bcf23e016ebc30fcbdb91d2dc95b2c81881a71a27a", "vars": {}, "terms": ["*(principal executive officer)*", "**$**", "**21,475,999.00**", "**AGREEMENT**", "**AMENDED AND RESTATED BUDGET**", "**AMENDMENT NO. 2**", "**Amendment No. 2 to Sublease Agreement**", "**Budget**", "**Disbursement Category**", "**MYRIAD PHASE V**", "**RECITALS**", "**SUBLEASE AGREEMENT**", "**Schedule 1**", "**TO**", "**To**", "**Total Project Costs**", "*President and Chief Executive Officer*", "\u201cBuilding\u201d", "\u201cLandlord\u201d", "\u201cLeased Premises\u201d", "\u201cProperty\u201d", "\u201cSecond Amendment\u201d", "\u201cSublease Agreement\u201d", "\u201cTenant\u201d"]}}